Genomic instability is a characteristic of most human cancers and plays critical roles in both cancer development and progression. There are various forms of genomic instability arising from many different pathways, such as DNA damage from endogenous and exogenous sources, centrosome amplification, telomere damage, and epigenetic modifications. DNA repair pathways can enable tumor cells to survive DNA damage. The failure to respond to DNA damage is a characteristic associated with genomic instability. Understanding of genomic instability in cancer is still very limited, but the further understanding of the molecular mechanisms through which the DNA damage response operates, in combination with the elucidation of the genetic interactions between DNA damage response pathways and other cell pathways, will provide therapeutic opportunities for the personalized medicine of cancer.
Targeting genome instability and DNA repair / M. Locatelli, G.C. - In: Breast Cancer : Innovations in Research and Management / [a cura di] U. Veronesi, A. Goldhirsch, P. Veronesi, O.D. Gentilini, M.C. Leonardi. - [s.l] : Springer International Publishing, 2017. - ISBN 978-3-319-48846-2. - pp. 795-805 [10.1007/978-3-319-48848-6_68]
Targeting genome instability and DNA repair
G. Curigliano
Ultimo
2017
Abstract
Genomic instability is a characteristic of most human cancers and plays critical roles in both cancer development and progression. There are various forms of genomic instability arising from many different pathways, such as DNA damage from endogenous and exogenous sources, centrosome amplification, telomere damage, and epigenetic modifications. DNA repair pathways can enable tumor cells to survive DNA damage. The failure to respond to DNA damage is a characteristic associated with genomic instability. Understanding of genomic instability in cancer is still very limited, but the further understanding of the molecular mechanisms through which the DNA damage response operates, in combination with the elucidation of the genetic interactions between DNA damage response pathways and other cell pathways, will provide therapeutic opportunities for the personalized medicine of cancer.| File | Dimensione | Formato | |
|---|---|---|---|
|
978-3-319-48848-6_68.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Licenza:
Nessuna licenza
Dimensione
305.87 kB
Formato
Adobe PDF
|
305.87 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.




